Pandion Therapeutics (PAND) Short Interest Ratio & Short Volume

Short interest is the volume of Pandion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 411,800 shares of PAND short. Learn More on Pandion Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PAND shares currently have a short interest ratio of 1.0. Learn More on Pandion Therapeutics's short interest ratio.

Pandion Therapeutics saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 411,800 shares, a decline of 57.1% from the previous total of 961,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to Pandion Therapeutics: Structure Therapeutics Inc. (9.03%), Schrödinger, Inc. (8.63%), NewAmsterdam Pharma (0.86%), Syndax Pharmaceuticals, Inc. (11.32%), Catalyst Pharmaceuticals, Inc. (6.06%), Harmony Biosciences Holdings, Inc. (20.65%), Amneal Pharmaceuticals, Inc. (2.17%), Avidity Biosciences, Inc. (12.52%), Avadel Pharmaceuticals plc (11.47%), Agios Pharmaceuticals, Inc. (12.06%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($5.63 billion), Charter Communications, Inc. ($5.41 billion), Analog Devices, Inc. ($5.32 billion), Baidu, Inc. ($4.45 billion), Snap Inc. ($3.86 billion), Warner Bros. Discovery, Inc. ($3.30 billion), Airbnb, Inc. ($2.82 billion), Bilibili Inc. ($2.34 billion), GameStop Corp. ($2.24 billion), and Expedia Group, Inc. ($2.21 billion). View all of the most shorted stocks.

Short selling PAND is an investing strategy that aims to generate trading profit from Pandion Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Pandion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PAND, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PAND, twice per month. The most recent reporting period available is March, 15 2021.